Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
72,000
Employees72,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
72,000
Employees72,000

BDX Key Statistics

Market cap
41.47B
Market cap41.47B
Price-Earnings ratio
39.63
Price-Earnings ratio39.63
Dividend yield
2.68%
Dividend yield2.68%
Average volume
3.12M
Average volume3.12M
High today
$159.68
High today$159.68
Low today
$150.35
Low today$150.35
Open price
$156.29
Open price$156.29
Volume
2.25M
Volume2.25M
52 Week high
$187.35
52 Week high$187.35
52 Week low
$129.03
52 Week low$129.03

Stock Snapshot

Becton Dickinson(BDX) stock is priced at $150.56, giving the company a market capitalization of 41.47B. It carries a P/E multiple of 39.63 and pays a dividend yield of 2.68%.

On 2026-07-09, Becton Dickinson(BDX) stock moved within a range of $150.35 to $159.68. With shares now at $150.56, the stock is trading +0.1% above its intraday low and -5.7% below the session's peak.

Trading activity shows a volume of 2.25M, compared to an average daily volume of 3.12M.

Over the past 52 weeks, Becton Dickinson(BDX) stock has traded between a high of $187.35 and a low of $129.03.

Over the past 52 weeks, Becton Dickinson(BDX) stock has traded between a high of $187.35 and a low of $129.03.

BDX News

Simply Wall St 21h
Becton Dickinson Following Its Veritor Shift And Index Changes Looks Undervalued

Becton Dickinson (BDX) has drawn attention after requesting that the FDA revoke the Emergency Use Authorization for its BD Veritor SARS-CoV-2 test, while also b...

Becton Dickinson Following Its Veritor Shift And Index Changes Looks Undervalued
TipRanks 3d
Becton Dickinson price target lowered to $180 from $190 at Evercore ISI

Evercore ISI lowered the firm’s price target on Becton Dickinson (BDX) to $180 from $190 and keeps an Outperform rating on the shares. The firm’s Q2 preview for...

Simply Wall St 3d
Does Vizient’s CentroVena One Deal and Index Shuffle Change The Bull Case For Becton Dickinson?

Becton Dickinson recently saw the FDA revoke the Emergency Use Authorization for its BD Veritor rapid SARS-CoV-2 test at the company’s request, while the firm w...

Does Vizient’s CentroVena One Deal and Index Shuffle Change The Bull Case For Becton Dickinson?

Analyst ratings

59%

of 17 ratings
Buy
41.2%
Hold
58.8%
Sell
0%

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.